The Cancer Drug Development Forum (CDDF) held a live webinar on “Clinical Research in Central and Eastern Europe, Realising the opportunities” on Monday 12 February 2024 at 17:00 (CET) / 11:00 (EST).
This webinar gave a pre-view of the discussions that are going to take place during the hybrid CDDF Multi-stakeholder workshop on Clinical Research in Central and Eastern Europe “New Approaches for the Next Level of Development”, taking place on 15-16 April 2024 in Krakow, Poland.
Three high-level speakers covered the following topics during this webinar:
- Dr Bhatti: The European Federation of Pharmaceutical Industries and Associations (EFPIA) is developing a new clinical trials strategy to have smarter, faster, more patient-centered trials in Europe. EFPIA recently surveyed their members to understand where there are gaps in the current state of clinical research and identify any barriers limiting or reducing the number of European sites/countries participating in clinical trials. Dr Bhatti shared the top-level survey results and explained which actions EFPIA think are needed to bring more innovative trials to Europe and create a thriving clinical trial ecosystem that enables their conduct.
- Prof Lawler presented some of the data intelligence that has been gathered on the impact of the war in Ukraine on cancer research and care and their implications. He will also highlight how lessons learnt can help to inform a reimagination of cancer research and care in post-conflict Ukraine and surrounding countries.
- Mr. Janicki shared the background on AstraZeneca’s unique global clinical organization in Poland which over the last several years has grown from 60 employees to more than 1 500. Wiktor explored key questions around why would Poland be considered as a good place for a global clinical hub and what were the key success factors for its development at AstraZeneca. He also shared his perspective on the future of cancer clinical research in Poland.
Agenda: (CET time zone)
17:00 – 17:05 Introduction – Axel Glasmacher (University of Bonn & CDDF Board Member, DE)
17:05 – 17:15 What do we need to change to have smarter, faster, more patient centered trials in Europe – Susan Bhatti (Merck BV, NL)
17:15 – 17:25 Deploying data to understand cancer research challenges and opportunities in Central and Eastern Europe – Mark Lawler (Queen’s University Belfast; CDDF Board Member, UK)
17:25 – 17:40 Does Poland have the potential to become the next cancer research hub – Wiktor Janicki (AstraZeneca, PL)
17:40 – 18:00 Discussion – moderated by Axel Glasmacher (University of Bonn & CDDF Board Member, DE) and Susan Bhatti (Merck BV, NL)